Three-Dimensional Hepatocyte Spheroids: Model for Assessing Chemotherapy in Hepatocellular Carcinoma.
dacarbazine
extracellular vesicles
methotrexate
primary hepatocyte
sorafenib
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
28 May 2024
28 May 2024
Historique:
received:
15
02
2024
revised:
13
05
2024
accepted:
22
05
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
epublish
Résumé
Three-dimensional cellular models provide a more comprehensive representation of in vivo cell properties, encompassing physiological characteristics and drug susceptibility. Primary hepatocytes were seeded in ultra-low attachment plates to form spheroids, with or without tumoral cells. Spheroid structure, cell proliferation, and apoptosis were analyzed using histological staining techniques. In addition, extracellular vesicles were isolated from conditioned media by differential ultracentrifugation. Spheroids were exposed to cytotoxic drugs, and both spheroid growth and cell death were measured by microscopic imaging and flow cytometry with vital staining, respectively. Concerning spheroid structure, an active outer layer forms a boundary with the media, while the inner core comprises a mass of cell debris. Hepatocyte-formed spheroids release vesicles into the extracellular media, and a decrease in the concentration of vesicles in the culture media can be observed over time. When co-cultured with tumoral cells, a distinct distribution pattern emerges over the primary hepatocytes, resulting in different spheroid conformations. Tumoral cell growth was compromised upon antitumoral drug challenges. Treatment of mixed spheroids with different cytotoxic drugs enables the characterization of drug effects on both hepatocytes and tumoral cells, determining drug specificity effects on these cell types.
Sections du résumé
BACKGROUND
BACKGROUND
Three-dimensional cellular models provide a more comprehensive representation of in vivo cell properties, encompassing physiological characteristics and drug susceptibility.
METHODS
METHODS
Primary hepatocytes were seeded in ultra-low attachment plates to form spheroids, with or without tumoral cells. Spheroid structure, cell proliferation, and apoptosis were analyzed using histological staining techniques. In addition, extracellular vesicles were isolated from conditioned media by differential ultracentrifugation. Spheroids were exposed to cytotoxic drugs, and both spheroid growth and cell death were measured by microscopic imaging and flow cytometry with vital staining, respectively.
RESULTS
RESULTS
Concerning spheroid structure, an active outer layer forms a boundary with the media, while the inner core comprises a mass of cell debris. Hepatocyte-formed spheroids release vesicles into the extracellular media, and a decrease in the concentration of vesicles in the culture media can be observed over time. When co-cultured with tumoral cells, a distinct distribution pattern emerges over the primary hepatocytes, resulting in different spheroid conformations. Tumoral cell growth was compromised upon antitumoral drug challenges.
CONCLUSIONS
CONCLUSIONS
Treatment of mixed spheroids with different cytotoxic drugs enables the characterization of drug effects on both hepatocytes and tumoral cells, determining drug specificity effects on these cell types.
Identifiants
pubmed: 38927406
pii: biomedicines12061200
doi: 10.3390/biomedicines12061200
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : HORIZON-HLTH-2022-STAYHLTH-02
ID : 101095679
Organisme : Funded by the European Union, EVCA Twining Project
ID : Horizon GA n° 101079264
Organisme : CIBEREHD-BBN COLLABORATION
ID : PROJECTS 2021
Organisme : Excellence Severo Ochoa grant Innovative Research Grant
ID : SEV-2016-0644
Organisme : MCIN/AEI /10.13039/501100011033 and FSE "invierte en tu futuro"
ID : Ayuda PRE2019-089221
Organisme : MCIN/AEI /10.13039/501100011033 and FSE+
ID : Ayuda PRE2022-103544
Organisme : Spanish Ministry of Science and Innovation - MCIN/ AEI /10.13039/501100011033/ and FEDER "una manera de hacer Europa".
ID : Proyecto PID2021-125104OB-I00